Divalproex Sodium
Product Images NDC 17856-0262

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 17856-0262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0262 01)

Label for Divalproex Sodium Extended-Release USP 500 mg tablets, packaged by Unit Dose Solutions and distributed by Atlantic Biologicals Corp. The package contains 100 tablets. Storage instructions specify 25°C with permitted excursions. The label includes product identification numbers, barcode, and a reorder phone number.*

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

Chemical structure of divalproex sodium, showing the sodium salt form of valproic acid with two valproate ions and associated sodium cation.*

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

A cumulative distribution plot comparing percentage reduction in CPS rate between Divalproex Sodium Delayed-Release and placebo. The x-axis shows the percentage of patients, and the y-axis shows percentage reduction in CPS rate, with improvement above zero and worsening below zero. Two lines depict outcomes for the drug (solid) and placebo (dashed).*

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

A line graph showing the percentage reduction in CPS rate versus the percentage of patients. The graph compares high dose and low dose Divalproex sodium delayed release, with improvement and worsening indicated on the vertical axis. High dose is represented by a solid line and low dose by a dashed line.*

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

A bar chart comparing the effects of Placebo and Divalproex Sodium Extended-Release Tablets. The chart shows higher values for Divalproex Sodium (black bar) compared to Placebo (white bar), with numerical values of approximately 1.2 and 0.6 respectively. Statistical significance is indicated with a p-value of 0.006.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.